OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma
Xiaoyu Wu, Liang Deng, Decai Tang, et al.
Tumor Biology (2015) Vol. 37, Iss. 5, pp. 6813-6821
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Reprogramming of serine, glycine and one-carbon metabolism in cancer
Albert M. Li, Jiangbin Ye
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 10, pp. 165841-165841
Open Access | Times Cited: 94

Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers
Wei Sun, Ruochen Liu, Xinyue Gao, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 34

A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight
Christine R. Cuthbertson, Zahra Arabzada, Armand Bankhead, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 624-646
Open Access | Times Cited: 35

Amino acid metabolic reprogramming in tumor metastatic colonization
Zihao Wang, Xingyun Wu, Hai‐Ning Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16

The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review
Sarun Juengpanich, Liang Shi, Yasaman Iranmanesh, et al.
Translational Oncology (2019) Vol. 12, Iss. 8, pp. 1092-1107
Open Access | Times Cited: 42

Circ-LAMP1 promotes T-cell lymphoblastic lymphoma progression via acting as a ceRNA for miR-615-5p to regulate DDR2 expression
Liling Deng, Guo‐Hua Liu, Chanjuan Zheng, et al.
Gene (2019) Vol. 701, pp. 146-151
Closed Access | Times Cited: 41

RETRACTED ARTICLE: The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway
Jiahui Du, Guangzhao Zhang, Hongli Qiu, et al.
Cellular & Molecular Biology Letters (2019) Vol. 24, Iss. 1
Open Access | Times Cited: 41

Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma
Bo Wang, Wei Wang, Zhizhong Zhu, et al.
Clinical Neurology and Neurosurgery (2017) Vol. 154, pp. 28-33
Closed Access | Times Cited: 36

MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells
Rowan Abdelbary, Manon Ragheb, Shereen Ahmed El Sobky, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access

Mechanism and Therapeutic Progress of One-Carbon Metabolic Key Enzyme: Serine Hydroxymethyltransferase 2 in Cancer
Siqiang Zhu, Yuan Liu, Hao Chen, et al.
Clinical Medicine Insights Oncology (2025) Vol. 19
Open Access

Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
Ming Wu, Siyi Wanggou, Xuejun Li, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 3781-3788
Open Access | Times Cited: 29

Curcumin and its Potential for Systemic Targeting of Inflamm-Aging and Metabolic Reprogramming in Cancer
Renata Novak Kujundžić, Višnja Stepanić, Lidija Milković, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1180-1180
Open Access | Times Cited: 28

Serine hydroxymethyltransferase 2: a novel target for human cancer therapy
Min Xie, Dong‐Sheng Pei
Investigational New Drugs (2021) Vol. 39, Iss. 6, pp. 1671-1681
Closed Access | Times Cited: 23

Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases
Xiang Li, Yaru Shao, Yuping Chen
Journal of drug targeting (2021) Vol. 29, Iss. 10, pp. 1080-1093
Closed Access | Times Cited: 22

Silencing SHMT2 inhibits the progression of tongue squamous cell carcinoma through cell cycle regulation
Yan Liao, Fang Wang, Yadong Zhang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 21

Analysis of Gene Expression Variance in Schizophrenia Using Structural Equation Modeling
Anna A. Igolkina, Chris Armoskus, Jeremy R. B. Newman, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 25

Noncoding RNAs within the HOX gene network in tumor pathogenesis and progression
Gerardo Botti, A. Chiara, Maurizio Di Bonito, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 1, pp. 395-413
Open Access | Times Cited: 25

miR-615 Fine-Tunes Growth and Development and Has a Role in Cancer and in Neural Repair
Marisol Godínez-Rubí, Daniel Ortuño‐Sahagún
Cells (2020) Vol. 9, Iss. 7, pp. 1566-1566
Open Access | Times Cited: 22

Identification of TWIST-interacting genes in prostate cancer
Peng Lyu, Shu‐Dong Zhang, Hiu‐Fung Yuen, et al.
Science China Life Sciences (2017) Vol. 60, Iss. 4, pp. 386-396
Closed Access | Times Cited: 24

HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression
Yang Yang, Minghui Zhang, Yaxuan Zhao, et al.
Cancer Science (2023) Vol. 114, Iss. 12, pp. 4583-4595
Open Access | Times Cited: 7

Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells
Emma B. Laursen, Jacob Fredsøe, Linnéa Schmidt, et al.
American Journal Of Pathology (2019) Vol. 189, Iss. 12, pp. 2377-2388
Open Access | Times Cited: 19

Page 1 - Next Page

Scroll to top